NCT03804424 2024-11-12
64Cu-LLP2A for Imaging Multiple Myeloma
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated
Clinical Trials
10 trialsNCT01390584 2023-06-29
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT03739281 2023-01-17
PET/MR Imaging in Lung Cancer
University Hospital of North Norway
Phase NA Terminated
NCT02834455 2020-12-17
REPEAT
Naestved Hospital
Phase NA Terminated
NCT02317302 2020-06-11
FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
Washington University School of Medicine
Phase 1 Terminated
NCT01479348 2020-06-02
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT02964988 2019-10-15
uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Rigshospitalet, Denmark
Phase 2 Terminated
NCT01744054 2018-03-05
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Washington University School of Medicine
Phase 1 Terminated
NCT02042053 2017-07-18
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
NYU Langone Health
Phase NA Terminated
NCT01569321 2015-04-21
Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study
Assistance Publique Hopitaux De Marseille
Phase NA Terminated